Hims & Hers Health (HIMS)
Hims & Hers Health on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as services-offices & clinics of doctors of medicine.
53.5M
Short interest
settlement 2026-10-15
5.0
Days to cover
-0.2 days vs prior
59.2%
Short share of volume
2026-10-28
34
Fails to deliver
settlement 2026-09-28
Mon 2 Nov
Next earnings
estimated date
-$4.0M
Insider flow, 90 days
0 buys, 13 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in HIMS is 53,473,095 shares, up 552,652 shares over the last month. Over the last 48 readings it ranged from 33,843,786 shares (31 October 2024) to 84,964,491 shares (27 February 2026). At the reported average volume of 10.7M shares a day that is 5.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/hims" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 53,473,095 | -2.4% | 10,679,092 | 5.01 |
| 2026-09-30 | 54,769,436 | +3.5% | 10,410,389 | 5.26 |
| 2026-09-15 | 52,920,443 | -3.7% | 8,639,996 | 6.13 |
| 2026-08-31 | 54,945,417 | -6.4% | 12,697,747 | 4.33 |
| 2026-08-14 | 58,674,597 | -5.7% | 13,079,862 | 4.49 |
| 2026-07-31 | 62,215,733 | +1.3% | 16,751,153 | 3.71 |
| 2026-07-15 | 61,410,121 | +0.4% | 13,580,710 | 4.52 |
| 2026-06-30 | 61,166,806 | -6.6% | 18,918,072 | 3.23 |
| 2026-06-15 | 65,472,703 | +4.6% | 18,560,107 | 3.53 |
| 2026-05-29 | 62,610,734 | -1.2% | 19,908,553 | 3.14 |
| 2026-05-15 | 63,372,020 | +0.3% | 25,855,597 | 2.45 |
| 2026-04-30 | 63,160,154 | -9.5% | 42,790,298 | 1.48 |
| 2026-04-15 | 69,774,819 | -2.2% | 23,188,241 | 3.01 |
| 2026-03-31 | 71,359,926 | -14.3% | 28,538,083 | 2.50 |
| 2026-03-13 | 83,286,092 | -2.0% | 63,754,242 | 1.31 |
| 2026-02-27 | 84,964,491 | +4.9% | 32,934,660 | 2.58 |
| 2026-02-13 | 81,010,101 | +5.5% | 47,181,723 | 1.72 |
| 2026-01-30 | 76,761,792 | +6.2% | 17,577,597 | 4.37 |
| 2026-01-15 | 72,251,095 | +7.7% | 16,419,348 | 4.40 |
| 2025-12-31 | 67,096,243 | +3.5% | 10,834,044 | 6.19 |
| 2025-12-15 | 64,816,789 | -3.7% | 14,009,237 | 4.63 |
| 2025-11-28 | 67,327,436 | -0.3% | 20,311,018 | 3.31 |
| 2025-11-14 | 67,552,266 | -3.7% | 34,326,686 | 1.97 |
| 2025-10-31 | 70,158,018 | +4.9% | 26,689,929 | 2.63 |
| 2025-10-15 | 66,883,420 | -5.8% | 30,028,606 | 2.23 |
| 2025-09-30 | 71,013,939 | +6.7% | 28,229,618 | 2.52 |
| 2025-09-15 | 66,534,489 | -10.8% | 29,826,022 | 2.23 |
| 2025-08-29 | 74,635,929 | +6.3% | 22,509,144 | 3.32 |
| 2025-08-15 | 70,218,527 | +8.7% | 35,464,164 | 1.98 |
| 2025-07-31 | 64,593,744 | -1.1% | 35,187,247 | 1.84 |
| 2025-07-15 | 65,295,727 | -4.5% | 27,215,052 | 2.40 |
| 2025-06-30 | 68,345,051 | +10.8% | 64,990,853 | 1.05 |
| 2025-06-13 | 61,690,896 | +1.3% | 44,515,981 | 1.39 |
| 2025-05-30 | 60,880,774 | -2.3% | 33,845,505 | 1.80 |
| 2025-05-15 | 62,338,753 | +0.1% | 72,001,530 | 1.00 |
| 2025-04-30 | 62,308,786 | +2.7% | 34,582,786 | 1.80 |
| 2025-04-15 | 60,657,151 | +5.0% | 24,669,048 | 2.46 |
| 2025-03-31 | 57,769,557 | +5.5% | 21,284,311 | 2.71 |
| 2025-03-14 | 54,733,233 | +5.6% | 23,751,612 | 2.30 |
| 2025-02-28 | 51,844,511 | +12.4% | 51,412,508 | 1.01 |
| 2025-02-14 | 46,122,316 | -20.8% | 20,172,156 | 2.29 |
| 2025-01-31 | 58,208,349 | +2.9% | 11,098,261 | 5.24 |
| 2025-01-15 | 56,576,887 | +8.6% | 9,648,851 | 5.86 |
| 2024-12-31 | 52,121,449 | +21.3% | 12,617,411 | 4.13 |
| 2024-12-13 | 42,972,111 | +0.8% | 12,702,729 | 3.38 |
| 2024-11-29 | 42,622,007 | +7.9% | 23,391,777 | 1.82 |
| 2024-11-15 | 39,517,672 | +16.8% | 28,341,801 | 1.39 |
| 2024-10-31 | 33,843,786 | +6.2% | 9,029,398 | 3.75 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of HIMS volume is 59.2%, down 0.7 points over the last five sessions. Over the last 30 readings it ranged from 50.8% (30 September 2026) to 75.8% (23 September 2026). The latest reading is in line with the 30-session average of 61.0%, on 5.4M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 3.2M | 5.4M | 59.2% | 3,734 |
| 2026-10-27 | 1.7M | 3.3M | 52.1% | 5,770 |
| 2026-10-26 | 1.4M | 2.3M | 62.9% | 6,084 |
| 2026-10-23 | 2.5M | 3.7M | 66.0% | 5,270 |
| 2026-10-22 | 2.2M | 3.6M | 63.0% | 7,822 |
| 2026-10-21 | 1.3M | 2.2M | 59.9% | 13,834 |
| 2026-10-20 | 2.3M | 3.8M | 62.5% | 8,645 |
| 2026-10-19 | 2.0M | 3.2M | 62.0% | 1,448 |
| 2026-10-16 | 2.7M | 4.1M | 66.2% | 15,921 |
| 2026-10-15 | 4.1M | 6.6M | 61.8% | 20,823 |
| 2026-10-14 | 2.6M | 4.4M | 58.8% | 29,860 |
| 2026-10-13 | 2.0M | 3.4M | 58.3% | 1,922 |
| 2026-10-12 | 2.6M | 4.3M | 59.6% | 13,252 |
| 2026-10-09 | 4.2M | 7.3M | 57.3% | 41,762 |
| 2026-10-08 | 3.5M | 5.6M | 62.7% | 4,926 |
| 2026-10-07 | 1.4M | 2.5M | 56.2% | 3,853 |
| 2026-10-06 | 2.1M | 3.6M | 58.0% | 8,593 |
| 2026-10-05 | 1.8M | 3.0M | 61.3% | 798 |
| 2026-10-02 | 2.7M | 4.6M | 59.5% | 3,409 |
| 2026-10-01 | 2.0M | 3.6M | 55.4% | 10,493 |
| 2026-09-30 | 3.2M | 6.4M | 50.8% | 66,371 |
| 2026-09-29 | 1.7M | 2.8M | 59.7% | 1,837 |
| 2026-09-28 | 1.7M | 2.8M | 62.6% | 2,690 |
| 2026-09-25 | 2.0M | 3.2M | 61.6% | 5,559 |
| 2026-09-24 | 4.0M | 6.4M | 62.5% | 23,250 |
| 2026-09-23 | 4.0M | 5.3M | 75.8% | 7,781 |
| 2026-09-22 | 4.3M | 6.8M | 63.5% | 16,875 |
| 2026-09-21 | 2.1M | 3.5M | 58.8% | 13,355 |
| 2026-09-18 | 2.5M | 3.5M | 72.4% | 17,425 |
| 2026-09-17 | 2.4M | 3.9M | 60.8% | 74,620 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 28 September 2026, the fails-to-deliver balance in HIMS is 34 shares, down 346 shares over the last settlement date. Over the last 30 readings it ranged from 15 shares (8 September 2026) to 359,654 shares (21 September 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-28 | 34 | $29.42 | $1K |
| 2026-09-25 | 380 | $29.28 | $11K |
| 2026-09-24 | 266,610 | $28.39 | $7.6M |
| 2026-09-23 | 88,132 | $30.43 | $2.7M |
| 2026-09-21 | 359,654 | $27.99 | $10.1M |
| 2026-09-18 | 35,940 | $27.89 | $1.0M |
| 2026-09-15 | 43,864 | $28.81 | $1.3M |
| 2026-09-09 | 25,400 | $28.17 | $716K |
| 2026-09-08 | 15 | $27.71 | $416 |
| 2026-09-04 | 5,418 | $27.82 | $151K |
| 2026-09-03 | 4,901 | $28.68 | $141K |
| 2026-08-31 | 32 | $28.84 | $923 |
| 2026-08-27 | 10,749 | $29.83 | $321K |
| 2026-08-26 | 73,885 | $31.75 | $2.3M |
| 2026-08-24 | 21,543 | $33.78 | $728K |
| 2026-08-21 | 176 | $31.86 | $6K |
| 2026-08-20 | 8,197 | $31.09 | $255K |
| 2026-08-19 | 8,296 | $27.39 | $227K |
| 2026-08-18 | 2,877 | $28.61 | $82K |
| 2026-08-17 | 7,961 | $28.15 | $224K |
| 2026-08-14 | 4,416 | $28.77 | $127K |
| 2026-08-10 | 200 | $31.59 | $6K |
| 2026-08-06 | 573 | $31.65 | $18K |
| 2026-08-05 | 1,121 | $32.16 | $36K |
| 2026-08-04 | 15,159 | $30.82 | $467K |
| 2026-08-03 | 61,579 | $27.77 | $1.7M |
| 2026-07-30 | 19,919 | $25.00 | $498K |
| 2026-07-29 | 19,870 | $29.32 | $583K |
| 2026-07-28 | 3,260 | $30.24 | $99K |
| 2026-07-24 | 91 | $32.74 | $3K |
Insider trades
SEC Form 4, newest first. JSONInsiders at HIMS reported 13 open-market sells worth $4.0M in the last 90 days and no open-market buys. Latest filing: Boughton Soleil (Chief Legal Officer) on 2026-10-14.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | Boughton Soleil | Chief Legal Officer | Sell | 3K | $29.06 | $101K | 297K |
| 2026-10-01 | Okupe Oluyemi | Chief Financial Officer | Sell | 2K | $29.70 | $59K | 235K |
| 2026-09-30 | Boughton Soleil | Chief Legal Officer | Sell | 3K | $29.17 | $101K | 301K |
| 2026-09-22 | Okupe Oluyemi | Chief Financial Officer | Sell | 29K | $29.95 | $877K | 237K |
| 2026-09-22 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 14K | $5.01 | $70K | 266K |
| 2026-09-17 | Okupe Oluyemi | Chief Financial Officer | Sell | 12K | $28.82 | $355K | 252K |
| 2026-09-16 | Boughton Soleil | Chief Legal Officer | Sell | 6K | $27.86 | $174K | 304K |
| 2026-09-15 | Elshenawy Mohamed | CTO | Sell | 8K | $28.39 | $226K | 186K |
| 2026-09-15 | Chi Michael | Chief Operating Officer | Sell | 14K | $28.39 | $398K | 457K |
| 2026-09-02 | Boughton Soleil | Chief Legal Officer | Sell | 3K | $28.33 | $98K | 311K |
| 2026-08-27 | Dudum Andrew | Chief Executive Officer | Other transaction | 978K | $0.00 | $0 | 103K |
| 2026-08-25 | Dudum Andrew | Chief Executive Officer | Gift | 463K | $0.00 | $0 | 0 |
| 2026-08-19 | Okupe Oluyemi | Chief Financial Officer | Sell | 5K | $29.99 | $148K | 264K |
| 2026-08-19 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 5K | $5.01 | $25K | 269K |
| 2026-08-19 | Boughton Soleil | Chief Legal Officer | Sell | 25K | $27.55 | $692K | 314K |
| 2026-08-18 | Autor Deborah M. | Chief Policy Officer | Sell | 17K | $27.85 | $467K | 49K |
| 2026-08-17 | Okupe Oluyemi | Chief Financial Officer | Sell | 9K | $27.89 | $262K | 264K |
| 2026-08-17 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 9K | $5.01 | $47K | 274K |
| 2026-08-14 | Payne Christopher D | Director | Exercise or conversion | 545 | price not stated in the filing | not stated | 35K |
| 2026-08-14 | Becklund Irene | PAO | Tax withholding | 6K | $28.15 | $183K | 14K |
| 2026-08-14 | Becklund Irene | PAO | Exercise or conversion | 14K | price not stated in the filing | not stated | 20K |
| 2026-08-14 | Elshenawy Mohamed | CTO | Tax withholding | 96K | $28.15 | $2.7M | 194K |
| 2026-08-14 | Elshenawy Mohamed | CTO | Exercise or conversion | 188K | price not stated in the filing | not stated | 289K |
| 2026-08-14 | WELLS DAVID B | Director | Exercise or conversion | 778 | price not stated in the filing | not stated | 230K |
| 2026-08-14 | Autor Deborah M. | Chief Policy Officer | Tax withholding | 16K | $28.15 | $455K | 66K |
| 2026-08-14 | Autor Deborah M. | Chief Policy Officer | Exercise or conversion | 33K | price not stated in the filing | not stated | 82K |
| 2026-08-14 | Okupe Oluyemi | Chief Financial Officer | Tax withholding | 36K | $28.15 | $1.0M | 264K |
| 2026-08-14 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 72K | price not stated in the filing | not stated | 301K |
| 2026-08-14 | Chi Michael | Chief Operating Officer | Tax withholding | 48K | $28.15 | $1.3M | 471K |
| 2026-08-14 | Chi Michael | Chief Operating Officer | Exercise or conversion | 86K | price not stated in the filing | not stated | 518K |
| 2026-08-14 | Dudum Andrew | Chief Executive Officer | Tax withholding | 79K | $28.15 | $2.2M | 1.0M |
| 2026-08-14 | Dudum Andrew | Chief Executive Officer | Exercise or conversion | 155K | price not stated in the filing | not stated | 1.1M |
| 2026-08-14 | Carroll Patrick Harrison | Chief Medical Officer | Tax withholding | 10K | $28.15 | $287K | 198K |
| 2026-08-14 | Carroll Patrick Harrison | Chief Medical Officer | Exercise or conversion | 26K | price not stated in the filing | not stated | 208K |
| 2026-08-14 | Carroll Patrick Harrison | Chief Medical Officer | Exercise or conversion | 260 | price not stated in the filing | not stated | 182K |
| 2026-08-14 | Schultz Kare | Director | Exercise or conversion | 7K | price not stated in the filing | not stated | 26K |
| 2026-08-14 | Boughton Soleil | Chief Legal Officer | Tax withholding | 22K | $28.15 | $605K | 339K |
| 2026-08-14 | Boughton Soleil | Chief Legal Officer | Exercise or conversion | 42K | price not stated in the filing | not stated | 361K |
| 2026-07-17 | Okupe Oluyemi | Chief Financial Officer | Sell | 7K | $31.99 | $229K | 284K |
| 2026-07-17 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 7K | $5.01 | $36K | 291K |
| 2026-07-06 | Okupe Oluyemi | Chief Financial Officer | Sell | 7K | $36.49 | $261K | 284K |
| 2026-07-06 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 7K | $5.01 | $36K | 291K |
| 2026-06-22 | Okupe Oluyemi | Chief Financial Officer | Sell | 18K | $34.03 | $619K | 284K |
| 2026-06-22 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 6K | $5.01 | $32K | 303K |
| 2026-06-18 | Carroll Patrick Harrison | Chief Medical Officer | Sell | 24K | $35.00 | $830K | 182K |
| 2026-06-18 | Okupe Oluyemi | Chief Financial Officer | Sell | 55K | $35.09 | $1.9M | 229K |
| 2026-06-17 | Elshenawy Mohamed | CTO | Sell | 30K | $31.50 | $946K | 101K |
| 2026-06-17 | Becklund Irene | PAO | Sell | 4K | $31.50 | $141K | 7K |
| 2026-06-17 | Chi Michael | Chief Operating Officer | Sell | 14K | $31.50 | $442K | 432K |
| 2026-06-16 | Becklund Irene | PAO | Sell | 8K | $30.25 | $229K | 11K |
| 2026-06-15 | Manuel Anja | Director | Exercise or conversion | 10K | price not stated in the filing | not stated | 39K |
| 2026-06-15 | Payne Christopher D | Director | Exercise or conversion | 647 | price not stated in the filing | not stated | 34K |
| 2026-06-15 | Payne Christopher D | Director | Exercise or conversion | 10K | price not stated in the filing | not stated | 34K |
| 2026-06-15 | Carroll Patrick Harrison | Chief Medical Officer | Exercise or conversion | 435 | price not stated in the filing | not stated | 188K |
| 2026-06-15 | WELLS DAVID B | Director | Exercise or conversion | 957 | price not stated in the filing | not stated | 229K |
| 2026-06-15 | Elshenawy Mohamed | CTO | Exercise or conversion | 283K | price not stated in the filing | not stated | 283K |
| 2026-06-15 | Elshenawy Mohamed | CTO | Tax withholding | 152K | $30.17 | $4.6M | 131K |
| 2026-06-15 | Dudum Andrew | Chief Executive Officer | Tax withholding | 86K | $30.17 | $2.6M | 957K |
| 2026-06-15 | Dudum Andrew | Chief Executive Officer | Exercise or conversion | 155K | price not stated in the filing | not stated | 1.0M |
| 2026-06-15 | Boughton Soleil | Chief Legal Officer | Exercise or conversion | 42K | price not stated in the filing | not stated | 342K |
| 2026-06-15 | Boughton Soleil | Chief Legal Officer | Tax withholding | 23K | $30.17 | $703K | 318K |
| 2026-06-15 | Becklund Irene | PAO | Tax withholding | 6K | $30.17 | $177K | 19K |
| 2026-06-15 | Becklund Irene | PAO | Exercise or conversion | 16K | price not stated in the filing | not stated | 25K |
| 2026-06-15 | Chi Michael | Chief Operating Officer | Exercise or conversion | 86K | price not stated in the filing | not stated | 494K |
| 2026-06-15 | Chi Michael | Chief Operating Officer | Tax withholding | 48K | $30.17 | $1.4M | 446K |
| 2026-06-15 | Autor Deborah M. | Chief Policy Officer | Exercise or conversion | 33K | price not stated in the filing | not stated | 64K |
| 2026-06-15 | Autor Deborah M. | Chief Policy Officer | Tax withholding | 15K | $30.17 | $464K | 49K |
| 2026-06-15 | Okupe Oluyemi | Chief Financial Officer | Tax withholding | 40K | $30.17 | $1.2M | 296K |
| 2026-06-15 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 72K | price not stated in the filing | not stated | 336K |
| 2026-06-15 | Carroll Patrick Harrison | Chief Medical Officer | Tax withholding | 8K | $30.17 | $251K | 206K |
| 2026-06-15 | Carroll Patrick Harrison | Chief Medical Officer | Exercise or conversion | 26K | price not stated in the filing | not stated | 214K |
| 2026-06-11 | Cosgrove Delos M. | Director | Exercise or conversion | 4K | price not stated in the filing | not stated | 68K |
| 2026-06-11 | Manuel Anja | Director | Exercise or conversion | 4K | price not stated in the filing | not stated | 29K |
| 2026-06-11 | Pendarvis Christiane | Director | Exercise or conversion | 4K | price not stated in the filing | not stated | 55K |
| 2026-06-11 | Payne Christopher D | Director | Exercise or conversion | 4K | price not stated in the filing | not stated | 24K |
| 2026-06-11 | Autor Deborah M. | Chief Policy Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 31K |
| 2026-06-11 | Carroll Patrick Harrison | Chief Medical Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 188K |
| 2026-06-11 | Perez Garcia Andrea G | Director | Exercise or conversion | 4K | price not stated in the filing | not stated | 84K |
| 2026-06-11 | Schultz Kare | Director | Exercise or conversion | 4K | price not stated in the filing | not stated | 19K |
| 2026-06-11 | WELLS DAVID B | Director | Exercise or conversion | 4K | price not stated in the filing | not stated | 228K |
| 2026-05-26 | WELLS DAVID B | Director | Buy | 48K | $24.23 | $1.2M | 224K |
| 2026-05-18 | Okupe Oluyemi | Chief Financial Officer | Sell | 8K | $23.64 | $188K | 263K |
| 2026-05-18 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 8K | $5.01 | $40K | 271K |
| 2026-04-20 | Okupe Oluyemi | Chief Financial Officer | Sell | 20K | $29.96 | $589K | 263K |
| 2026-04-20 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 7K | $11.53 | $81K | 283K |
| 2026-04-20 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 6K | $5.01 | $28K | 276K |
| 2026-04-20 | Boughton Soleil | Chief Legal Officer | Sell | 9K | $30.00 | $284K | 299K |
| 2026-04-17 | Okupe Oluyemi | Chief Financial Officer | Sell | 18K | $27.83 | $501K | 270K |
| 2026-04-17 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 6K | $5.01 | $31K | 288K |
| 2026-04-16 | Okupe Oluyemi | Chief Financial Officer | Sell | 37K | $25.90 | $956K | 282K |
| 2026-04-09 | Dudum Andrew | Chief Executive Officer | Gift | 423K | price not stated in the filing | not stated | 888K |
| 2026-04-09 | Dudum Andrew | Chief Executive Officer | Gift | 423K | price not stated in the filing | not stated | 470K |
| 2026-04-06 | Okupe Oluyemi | Chief Financial Officer | Sell | 4K | $19.98 | $79K | 319K |
| 2026-04-06 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 4K | $5.01 | $20K | 323K |
| 2026-03-20 | Okupe Oluyemi | Chief Financial Officer | Sell | 9K | $23.77 | $219K | 319K |
| 2026-03-20 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 4K | $5.01 | $22K | 328K |
| 2026-03-17 | Chi Michael | Chief Operating Officer | Sell | 97K | $24.69 | $2.4M | 407K |
| 2026-03-17 | Boughton Soleil | Chief Legal Officer | Sell | 5K | $24.69 | $119K | 309K |
| 2026-03-17 | Becklund Irene | PAO | Sell | 6K | $24.69 | $137K | 9K |
| 2026-03-13 | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion | 105K | price not stated in the filing | not stated | 381K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON44 Form 144 notices on file for HIMS worth $37.4M at the prices reported; 12 in the last 90 days worth $3.6M. Latest: Boughton Soleil filed on 2026-10-28 to sell 3,462 shares ($96K) from 2026-10-28.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-10-28 | Boughton SoleilOfficer | 3K | $96K | 0.002% | 2026-10-28 | Fidelity Brokerage Services LLC |
| 2026-10-14 | Boughton SoleilOfficer | 3K | $101K | 0.002% | 2026-10-14 | Fidelity Brokerage Services LLC |
| 2026-10-01 | Okupe OluyemiOfficer | 2K | $59K | 0.001% | 2026-10-01 | Fidelity Brokerage Services LLC |
| 2026-09-30 | Boughton SoleilOfficer | 3K | $101K | 0.002% | 2026-09-30 | Fidelity Brokerage Services LLC |
| 2026-09-22 | Okupe OluyemiOfficer | 29K | $877K | 0.013% | 2026-09-22 | Fidelity Brokerage Services LLC |
| 2026-09-17 | Okupe OluyemiOfficer | 12K | $355K | 0.005% | 2026-09-17 | Fidelity Brokerage Services LLC |
| 2026-09-16 | Boughton SoleilOfficer | 6K | $174K | 0.003% | 2026-09-16 | Fidelity Brokerage Services LLC |
| 2026-09-15 | Chi MichaelOfficer | 14K | $398K | 0.006% | 2026-09-15 | Fidelity Brokerage Services LLC |
| 2026-09-15 | Elshenawy MohamedOfficer | 8K | $226K | 0.004% | 2026-09-15 | Fidelity Brokerage Services LLC |
| 2026-09-02 | Boughton SoleilOfficer | 3K | $98K | 0.002% | 2026-09-02 | Fidelity Brokerage Services LLC |
| 2026-08-19 | Boughton SoleilOfficer | 25K | $692K | 0.011% | 2026-08-19 | Fidelity Brokerage Services LLC |
| 2026-08-18 | Autor Deborah M.Officer, Director | 17K | $467K | 0.007% | 2026-08-18 | Fidelity Brokerage Services LLC |
| 2026-07-22 | Pendarvis ChristianeFormer Director | 4K | $113K | 0.002% | 2026-07-22 | Fidelity Brokerage Services LLC |
| 2026-06-18 | Carroll Patrick HarrisonOfficer | 24K | $830K | 0.011% | 2026-06-18 | Fidelity Brokerage Services LLC |
| 2026-06-17 | Elshenawy MohamedOfficer | 30K | $946K | 0.013% | 2026-06-17 | Fidelity Brokerage Services LLC |
| 2026-06-17 | Chi MichaelOfficer | 14K | $442K | 0.006% | 2026-06-17 | Fidelity Brokerage Services LLC |
| 2026-06-17 | Becklund IreneOfficer | 4K | $141K | 0.002% | 2026-06-17 | Fidelity Brokerage Services LLC |
| 2026-06-16 | Becklund IreneOfficer | 8K | $229K | 0.003% | 2026-06-16 | Fidelity Brokerage Services LLC |
| 2026-04-20 | Boughton SoleilOfficer | 9K | $284K | 0.004% | 2026-04-20 | Fidelity Brokerage Services LLC |
| 2026-03-17 | Chi MichaelOfficer | 97K | $2.4M | 0.044% | 2026-03-17 | Fidelity Brokerage Services LLC |
| 2026-03-17 | Boughton SoleilOfficer | 5K | $119K | 0.002% | 2026-03-17 | Fidelity Brokerage Services LLC |
| 2026-03-17 | Becklund IreneOfficer | 6K | $137K | 0.003% | 2026-03-17 | Fidelity Brokerage Services LLC |
| 2026-02-27 | Boughton SoleilOfficer | 5K | $71K | 0.002% | 2026-02-27 | Fidelity Brokerage Services LLC |
| 2025-12-17 | Chi MichaelOfficer | 14K | $505K | 0.006% | 2025-12-17 | Fidelity Brokerage Services LLC |
| 2025-12-17 | Carroll Patrick HarrisonOfficer, Director | 10K | $368K | 0.005% | 2025-12-17 | Fidelity Brokerage Services LLC |
| 2025-12-17 | Becklund IreneOfficer | 8K | $309K | 0.004% | 2025-12-17 | Fidelity Brokerage Services LLC |
| 2025-12-17 | Autor Deborah M.Officer, Director | 7K | $259K | 0.003% | 2025-12-17 | Fidelity Brokerage Services LLC |
| 2025-12-09 | Perez Garcia Andrea GDirector | 3K | $98K | 0.001% | 2025-12-09 | Fidelity Brokerage Services LLC |
| 2025-11-24 | Boughton SoleilOfficer | 3K | $92K | 0.001% | 2025-11-24 | Fidelity Brokerage Services LLC |
| 2025-11-10 | Boughton SoleilOfficer | 3K | $112K | 0.001% | 2025-11-10 | Fidelity Brokerage Services LLC |
| 2025-10-27 | Boughton SoleilOfficer | 3K | $132K | 0.001% | 2025-10-27 | Fidelity Brokerage Services LLC |
| 2025-10-16 | Dudum AndrewOfficer, Director | 176K | $11.0M | 0.081% | 2025-10-16 | Fidelity Brokerage Services LLC |
| 2025-10-14 | Boughton SoleilOfficer | 3K | $143K | 0.001% | 2025-10-13 | Fidelity Brokerage Services LLC |
| 2025-10-10 | Chi MichaelOfficer | 900 | $52K | 0.000% | 2025-10-10 | Fidelity Brokerage Services LLC |
| 2025-10-01 | Chi MichaelOfficer | 250 | $14K | 0.000% | 2025-10-01 | Fidelity Brokerage Services LLC |
| 2025-09-29 | Boughton SoleilOfficer | 3K | $155K | 0.001% | 2025-09-29 | Fidelity Brokerage Services LLC |
| 2025-09-24 | Chi MichaelOfficer | 2K | $119K | 0.001% | 2025-09-24 | Fidelity Brokerage Services LLC |
| 2025-09-17 | Dudum AndrewOfficer, Director | 65K | $3.3M | 0.030% | 2025-09-17 | Fidelity Brokerage Services LLC |
| 2025-09-17 | Chi MichaelOfficer | 14K | $694K | 0.006% | 2025-09-17 | Fidelity Brokerage Services LLC |
| 2025-09-17 | Carroll Patrick HarrisonOfficer, Director | 10K | $506K | 0.005% | 2025-09-17 | Fidelity Brokerage Services LLC |
| 2025-09-17 | Boughton SoleilOfficer | 3K | $133K | 0.001% | 2025-09-17 | Fidelity Brokerage Services LLC |
| 2025-09-17 | Becklund IreneOfficer | 8K | $425K | 0.004% | 2025-09-17 | Fidelity Brokerage Services LLC |
| 2025-09-16 | Dudum AndrewOfficer, Director | 176K | $9.4M | 0.081% | 2025-09-16 | Fidelity Brokerage Services LLC |
| 2025-09-15 | Chi MichaelOfficer | 4K | $232K | 0.002% | 2025-09-15 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON7 holders report 5% or more of HIMS in their latest filing, 1 on Schedule 13D (active intent). The largest reported stake is BlackRock, Inc. at 11.9% of the class (26,496,218 shares), filed 2026-07-28 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-31 | 13D/Ano. 4 | Andrew Dudumindividual | 22.6M | 9.4% | 2026-08-27 |
| 2026-07-31 | 13G | Vanguard Capital Managementinvestment adviser | 11.2M | 5.0% | 2026-06-30 |
| 2026-07-28 | 13G/Ano. 3 | BlackRock, Inc.parent holding company | 26.5M | 11.9% | 2026-06-30 |
| 2026-05-15 | 13G | Susquehanna Securities, LLCbroker-dealer, other entity | 14.5M | 6.5% | 2026-03-31 |
| 2026-05-15 | 13G | Susquehanna Investment Groupbroker-dealer, partnership | 14.5M | 6.5% | 2026-03-31 |
| 2026-05-15 | 13G | SIG Brokerage, LPbroker-dealer, partnership | 14.5M | 6.5% | 2026-03-31 |
| 2026-05-15 | 13G | G1 Execution Services, LLCbroker-dealer, other entity | 14.5M | 6.5% | 2026-03-31 |
| 2026-05-14 | 13G/Ano. 2 | Capital World Investorsinvestment adviser | 2 | 0.0% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 5 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-03-05 | 13G/Ano. 1 | JPMORGAN CHASE & CO.parent holding company | 3.9M | 1.7% | 2026-02-27 |
13F holders
Tracked managers holding HIMS at their latest 13F. JSON4 of the 30 tracked managers held HIMS at their latest 13F, $42.6M in total at quarter-end prices. Citadel Advisors is the largest at $29.4M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 847K | $29.4M | 0.00% | +152K |
| AQR Capital Management | 2026-06-30 | 210K | $7.1M | 0.00% | +139K |
| D. E. Shaw & Co. | 2026-06-30 | 172K | $5.9M | 0.00% | -423K |
| Bridgewater Associates | 2026-06-30 | 7K | $244K | 0.00% | -35K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Hims & Hers Health reported revenue of $753.2M, up 38.2% from the same quarter a year earlier, and net loss of $86.3M (-0.37 diluted EPS). In FY 2025 it generated $300.0M of operating cash flow and spent $90.0M on buybacks.
- Cash
- $609.8M
- Equity
- $324.1M
- Total assets
- $3.63B
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $753.2M | -$86.3M | -11.5% | -0.37 |
| Q1 FY 2026 | 2026-03-31 | $608.1M | -$92.1M | -15.1% | -0.40 |
| Q4 FY 2025derived | 2025-12-31 | $617.8M | $20.6M | 3.3% | n/a |
| Q3 FY 2025 | 2025-09-30 | $599.0M | $15.8M | 2.6% | 0.06 |
| Q2 FY 2025 | 2025-06-30 | $544.8M | $42.5M | 7.8% | 0.17 |
| Q1 FY 2025 | 2025-03-31 | $586.0M | $49.5M | 8.4% | 0.20 |
| Q4 FY 2024derived | 2024-12-31 | $481.1M | $26.0M | 5.4% | n/a |
| Q3 FY 2024 | 2024-09-30 | $401.6M | $75.6M | 18.8% | 0.32 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2.35B | $128.4M | $300.0M | $242.6M | $90.0M | n/a |
| FY 2024 | 2024-12-31 | $1.48B | $126.0M | $251.1M | $52.8M | $83.0M | n/a |
| FY 2023 | 2023-12-31 | $872.0M | -$23.5M | $73.5M | $26.5M | $2.0M | n/a |
| FY 2022 | 2022-12-31 | $526.9M | -$65.7M | -$26.5M | $7.2M | $0 | n/a |
| FY 2021 | 2021-12-31 | $271.9M | -$107.7M | -$34.4M | n/a | $0 | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30.
What this page is
Hims & Hers Health in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Hims & Hers Health (HIMS), SEC CIK 1773751, listed on NYSE, classified by the SEC as services-offices & clinics of doctors of medicine. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-28.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-28.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-31.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-10.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-14.JSON and CSV
- Company record
- EDGAR filing index for CIK 1773751Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-offices & clinics of doctors of medicine
Other company pages
- AGXArgan
- AHRAmerican Healthcare REIT
- AIGAmerican International Group
- AJGArthur J. Gallagher
- AKAMAkamai Technologies
- ALABAstera Labs
- ALBAlbemarle
- ALGNAlign Technology
- ALHCAlignment Healthcare
- ALLAllstate
- ALLEAllegion
- ALLYAlly Financial
- ALMSAlumis
- ALNYAlnylam Pharmaceuticals
- AMATApplied Materials
- AMBAAmbarella
- AMCRAmcor
- AMDAdvanced Micro Devices
- AMEAMETEK
- AMGNAmgen
Datasets
Frequently Asked Questions
How much of HIMS is sold short?
53,473,095 shares were held short at the 2026-10-15 settlement, 5.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is HIMS's daily short volume?
On 2026-10-28, 3,214,217 of the 5,432,373 HIMS shares reported to FINRA were sold short, 59.2% of the day's reported volume. Short volume is a flow for one day, not a position.
Does HIMS have fails to deliver?
The SEC's latest file shows 34 HIMS shares failed to deliver at settlement 2026-09-28. Fails are reported per settlement date and published twice a month with a lag.
Are HIMS insiders buying or selling?
Insiders at HIMS reported 13 open-market sells worth $4.0M in the last 90 days and no open-market buys. Latest filing: Boughton Soleil (Chief Legal Officer) on 2026-10-14.
Have HIMS insiders filed to sell?
44 Form 144 notices on file for HIMS worth $37.4M at the prices reported; 12 in the last 90 days worth $3.6M. Latest: Boughton Soleil filed on 2026-10-28 to sell 3,462 shares ($96K) from 2026-10-28.
Who owns 5% or more of HIMS?
7 holders report 5% or more of HIMS in their latest filing, 1 on Schedule 13D (active intent). The largest reported stake is BlackRock, Inc. at 11.9% of the class (26,496,218 shares), filed 2026-07-28 for an event on 2026-06-30.
What did HIMS report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Hims & Hers Health reported revenue of $753.2M, up 38.2% from the same quarter a year earlier, and net loss of $86.3M (-0.37 diluted EPS). In FY 2025 it generated $300.0M of operating cash flow and spent $90.0M on buybacks.
Which tracked 13F managers own HIMS?
4 of the 30 tracked 13F managers held HIMS shares at their latest filing, $42.6M in all. The largest: Ken Griffin's Citadel Advisors (847K shares, $29.4M), Cliff Asness's AQR Capital Management (210K shares, $7.1M), D. E. Shaw & Co. (172K shares, $5.9M), Ray Dalio's Bridgewater Associates (7K shares, $244K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.